While the HHS public health emergency is ending, COVID-19 remains a high priority and the U.S. Food and Drug Administration will remain engaged with numerous activities to protect and promote public health.
First lessons from government evaluations of COVID-19 responses: A synthesis
Frontiers China's Public Health Policies in Response to COVID-19: From an “Authoritarian” Perspective
COVID-19 and Human Development: Assessing the Crisis, Envisioning the Recovery
Is Your Facility Prepared for the Next Pandemic?
Lessons Learned from COVID-19 Are Informing Preparation for Future Public Health Emergencies
Health research system resilience: lesson learned from the COVID-19 crisis, Health Research Policy and Systems
FDA Roundup: May 12, 2023 - US FDA
Protecting Public Health During the COVID-19 Pandemic: PHI Response & Resources - Public Health Institute
Public Health Crisis Playbook
AnaBot: Enhance ChatGPT Conversations & Insights